secwatch / observer
8-K filed November 17, 2022, 6:59 PM ET ticker DLB CIK 0001308547
earnings confidence high sentiment negative materiality 0.70

Dolby reports Q4 revenue $278.2M (-2% YoY) and GAAP EPS $0.28; FY revenue $1.25B; dividend $0.27

Dolby Laboratories, Inc.

2022-FY EPS reported $1.81 revenue$1,253,793,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Dolby Laboratories, Inc. reported Full Year Fiscal 2022 results: revenue $1.25 billion, net income $184.1 million, EPS $1.81 per diluted share.

Period
Full Year Fiscal 2022
Revenue
$1.25 billion
Net income
$184.1 million
EPS
$1.81 per diluted share
Result
reported results
Exact text from the filing
Total revenue was $1.25 billion, compared to $1.28 billion for the full year of fiscal 2021. GAAP net income was $184.1 million, or $1.81 per diluted share, compared to GAAP net income of $310.2 million, or $2.97 per diluted share, for the full year of fiscal 2021.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Dolby Laboratories, Inc. reported Fourth Quarter Fiscal 2022 results: revenue $278.2 million, net income $27.8 million, EPS $0.28 per diluted share.

Period
Fourth Quarter Fiscal 2022
Revenue
$278.2 million
Net income
$27.8 million
EPS
$0.28 per diluted share
Result
reported results
Exact text from the filing
Total revenue was $278.2 million, compared to $285.0 million for the fourth quarter of fiscal 2021. GAAP net income was $27.8 million, or $0.28 per diluted share, compared to GAAP net income of $44.2 million, or $0.42 per diluted share, for the fourth quarter of fiscal 2021.
View on SEC.gov

Browse all earnings releases →

Dolby Laboratories, Inc. filing history →

Source: SEC EDGAR
accession 0001171843-22-007571
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.